The role of anti-VEGF agents in myopic choroidal neovascularization: Current standards and future outlook.
about
A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization[Secondary diseases in high myopia].Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age.LONG-TERM OUTCOMES OF RANIBIZUMAB TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION IN EAST-ASIAN PATIENTS FROM THE RADIANCE STUDY.
P2860
The role of anti-VEGF agents in myopic choroidal neovascularization: Current standards and future outlook.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The role of anti-VEGF agents i ...... standards and future outlook.
@en
type
label
The role of anti-VEGF agents i ...... standards and future outlook.
@en
prefLabel
The role of anti-VEGF agents i ...... standards and future outlook.
@en
P2860
P50
P1476
The role of anti-VEGF agents i ...... t standards and future outlook
@en
P2093
Marion R Munk
Rene Rückert
P2860
P304
P356
10.1517/14712598.2016.1132696
P407
P577
2016-02-12T00:00:00Z